Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines
Parkinson's Disease · 2022-01 · 2022 (1)
DOI: 10.1155/2022/2700227 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Parkinson's Disease, online erschienen am 16.03.2022. Verfasst von Abdullah Al-Danakh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116021, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose of the Review . Posterior tibial nerve stimulation (PTNS) techniques have dramatically grown after approval to manage overactive bladder (OAB). The present review will focus on the most current data on PTNS types (percutaneous, transcutaneous, and implant) and their mechanism of action, safety, efficacy, advantages, drawbacks, limitation, and clinical applications. Recent Findings . The present review described the recent studies that addressed the tibial nerve stimulation role in OAB management. BlueWind RENOVA system, Bioness StimRouter, and eCoin are examples of emerging technologies that have evolved from interval sessions (percutaneous PTNS and transcutaneous PTNS) to continuous stimulation (implants). These can be efficiently managed at home by patients with minimum burden on the health system and fewer visits, especially in the COVID‐19 pandemic. Summary . Our review shows that the tibial nerve stimulation advancements in OAB treatment have been rapidly increasing over the recent years. It is minimally invasive and effective, similar to sacral nerve stimulation (SNM), but less aggressive. Implantable PTNS has been promised in terms of efficacy, safety, and high acceptance rate. However, evidence is still limited to short‐term trials, and tolerability, method, and drawbacks remain challenges.
Autor:innen und Institutionen
- Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian 116021, China.
- Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian 116021, China.
- Department of Urology, Second Affiliated Hospital of Dalian Medical University, Dalian 116021, China.
- Department of Pharmacology, Pharmaceutical College, Dalian Medical University, Dalian 116044, China.
- Department of Neurology, First Affiliated Hospital, Dalian Medical University, Dalian 116021, China.
- Department of Biochemistry, Faculty of Science, Ibb University, Ibb, Yemen.
ORCID-Profile: Abdullah Al-Danakh, Mohammed Safi, Mohammed Alradhi, Marwan Almoiliqy, Xinqing Zhu, Deyong Yang
Zitieren
APA
Al-Danakh, A., Safi, M., Alradhi, M., Almoiliqy, M., Chen, Q., Al-Nusaif, M., Yang, X., Al-Dherasi, A., Zhu, X., & Yang, D. (2022). Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines. Parkinson's Disease, 2022(1). https://doi.org/10.1155/2022/2700227
Vancouver
Al-Danakh A, Safi M, Alradhi M, Almoiliqy M, Chen Q, Al-Nusaif M, et al. Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines. Parkinson's Disease. 2022;2022(1). doi:10.1155/2022/2700227
BibTeX
@article{AlDanakh2022,
author = {Al-Danakh, Abdullah and Safi, Mohammed and Alradhi, Mohammed and Almoiliqy, Marwan and Chen, Qiwei and Al-Nusaif, Murad and Yang, Xuehan and Al-Dherasi, Aisha and Zhu, Xinqing and Yang, Deyong},
title = {Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines},
journal = {Parkinson's Disease},
year = {2022},
volume = {2022},
number = {1},
doi = {10.1155/2022/2700227}
}
EUVIMED